Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.
Fiche publication
Date publication
février 2017
Journal
Quantitative imaging in medicine and surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie, Pr CORMIER Luc, Pr LOFFROY Romaric
Tous les auteurs :
Bardin F, Chevallier O, Bertaut A, Delorme E, Moulin M, Pottecher P, Di Marco L, Gehin S, Mourey E, Cormier L, Mousson C, Midulla M, Loffroy R
Lien Pubmed
Résumé
Angiomyolipoma (AML) is the most common renal benign tumor. Treatment should be considered for symptomatic patients or for those at risk for complications, especially retroperitoneal bleeding which is correlated to tumor size, grade of the angiogenic component and to the presence of tuberous sclerosis complex (TSC). This study reports our single-center experience with the use of selective arterial embolization (SAE) in the management of symptomatic and asymptomatic renal AMLs.
Mots clés
Renal tumor, angiomyolipoma (AML), arterial embolization, bleeding patient, outcomes, therapeutic response
Référence
Quant Imaging Med Surg. 2017 Feb;7(1):8-23